Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics & Policy
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics & Policy
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Top News & Analysis

Health and Science

  • Biotech and Pharma
  • Health Insurance
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Annika Kim ConstantinoTue, Oct 13th 2026
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs
Annika Kim ConstantinoTue, Oct 13th 2026
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock
Alexa LoMonacoMon, Oct 12th 2026
Jim Cramer week ahead: Bank earnings, ASML and TSMC
Jim Cramer week ahead: Bank earnings, ASML and TSMC
Alexa LoMonacoFri, Oct 9th 2026
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come
Gerry SmithFri, Oct 9th 2026
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday
Politics & Policy
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday
Wed, Oct 7th 2026
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia
Politics & Policy
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia
Wed, Oct 7th 2026
Jim Cramer says Grail can run higher as FDA decision on Galleri nears
Mad Money
Jim Cramer says Grail can run higher as FDA decision on Galleri nears
Tue, Oct 6th 2026

Trending Now

  • 1
    Consumer prices rose at 3.7% annual rate in September as gas costs skyrocket
  • 2
    Iran says it’s ‘counting the moments’ until it can attack U.S. warships; Saudi Aramco facilities attacked
  • 3
    Stock futures fall into the red as hot inflation report sends yields higher: Live updates
  • 4
    Social Security cost-of-living adjustment for 2027 may be above average. Some say it's not enough
  • 5
    10-year Treasury yield jumps as September core inflation comes in hotter than expected

More In Health and Science

Russian lab worker's suspected plague death leaves experts puzzled
Health and Science
Russian lab worker's suspected plague death leaves experts puzzled
Tue, Oct 6th 2026
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk
Politics & Policy
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk
Mon, Oct 5th 2026
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos
Health and Science
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos
Mon, Oct 5th 2026
Health and Science
Russian lab worker dies amid plague reports. Here's what we know
Mon, Oct 5th 2026
Health and Science
Russia hospitalizes almost 200 people after death from plague: Reports
Mon, Oct 5th 2026
CNBC Cures
BioMarin reports five-year Pompe disease data showing durable motor function
Fri, Oct 2nd 2026
Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s
Health and Science
Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s
Fri, Oct 2nd 2026
Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
Health and Science
Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
Fri, Oct 2nd 2026
De-risking rare disease drug development
CNBC Cures
De-risking rare disease drug development
Thu, Oct 1st 2026
Morning Meeting
Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock
Thu, Oct 1st 2026
CNBC Work
$942 million: Insurer points finger at AI as suspect hospital charges appear
Thu, Oct 1st 2026
Tech
Grindr expands beyond dating with $250 million PurposeMed acquisition
Wed, Sep 30th 2026
Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial
Health and Science
Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial
Wed, Sep 30th 2026
Novo's Wegovy pill improves weight loss after people switch from injections
Health and Science
Novo's Wegovy pill improves weight loss after people switch from injections
Wed, Sep 30th 2026
White House moves to block $810 million in funding through pocket rescission
Politics & Policy
White House moves to block $810 million in funding through pocket rescission
Mon, Sep 28th 2026
Health and Science
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
Fri, Sep 25th 2026
CNBC Cures
NIH cuts delayed a cancer trial. Patients lost time they didn't have
Tue, Oct 6th 2026
Homestretch
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Thu, Sep 24th 2026
Novo's new strategy hinges on something it can't manufacture: investor trust
Health and Science
Novo's new strategy hinges on something it can't manufacture: investor trust
Thu, Sep 24th 2026
Trump administration removes around 760,000 Obamacare enrollments
Health and Science
Trump administration removes around 760,000 Obamacare enrollments
Tue, Sep 22nd 2026
Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage
Health and Science
Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage
Mon, Sep 21st 2026
Health and Science
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo
Mon, Sep 21st 2026
Retail
Why more companies are fighting over beauty, health and wellness spending
Fri, Sep 18th 2026
Politics & Policy
Mitch McConnell returns to Senate after three-month health absence
Tue, Sep 15th 2026
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo